Van Lanschot Kempen: 2023 AGM decisions and outcomes
Amsterdam/’s-Hertogenbosch, the Netherlands, 25May 2023
On 25 May 2023, Van Lanschot Kempen shareholders adopted the 2022 financial statements during the annual general meeting of shareholders (AGM) held in ‘s-Hertogenbosch.
The AGM appointed Elizabeth Nolan and reappointed Frans Blom as members of the Supervisory Board.
In addition, Van Lanschot Kempen’s shareholders approved the proposed payment of a cash dividend of €1.75 per Class A ordinary share.
All other agenda items were adopted as well.
The full agenda and notes are available at vanlanschotkempen.com/agm.
FINANCIAL CALENDAR
29 May 2023 Ex-dividend date
6 June 2023 2022 dividend payment date
24 August 2023 Publication of 2023 half-year results
2 November 2023 Publication of 2023 third-quarter trading update
Media Relations: +31 20 354 45 85; mediarelations@vanlanschotkempen.com
Investor Relations: +31 20 354 45 90; investorrelations@vanlanschotkempen.com
About Van Lanschot Kempen
Van Lanschot Kempen is an independent, specialist wealth manager active in private banking, investment management and investment banking, with the aim of preserving and creating wealth, in a sustainable way, for both its clients and the society of which it is part. Through our long-term focus, we create positive financial and non-financial value. Listed at Euronext Amsterdam, Van Lanschot Kempen is the Netherlands’ oldest independent financial services company, with a history dating back to 1737.
For more information, please visit vanlanschotkempen.com
Disclaimer
This press release does not constitute an offer or solicitation for the sale, purchase or acquisition in any other way or subscription to any financial instrument and is not a recommendation to perform or refrain from performing any action.
This press release is a translation of the Dutch language original and is provided as a courtesy only. In the event of any disparities, the Dutch language version will prevail. No rights can be derived from any translation thereof.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Correction: Aspocomp’s Interim Report January 1 – March 31, 2024: Net sales and operating result decreased from the comparison period18.4.2024 08:45:00 CEST | Press release
Aspocomp Group Plc, Interim Report, April 18, 2024, at 9:45 a.m. (Finnish time) Intangible assets in the Consolidated Balance sheet corrected FIRST QUARTER 2024 HIGHLIGHTS Net sales EUR 6.2 (8.9) million, decrease of 30%Operating result EUR -1.6 (0.3) million, -25.9% (3.8%) of net salesEarnings per share EUR -0.24 (0.04)Operative cash flow EUR -2.0 (1.6) millionOrders received EUR 7.5 (13.7) million, decrease of 45%Order book at the end of the review period EUR 11.8 (19.1) million, decrease of 38%Equity ratio 64.5% (72.9%) OUTLOOK FOR 2024 Inflation and interest rates, weak economic development, the uncertainties posed by Russia’s war of aggression and the situation in the Middle East, and global trade policy tensions will affect the operating environment of Aspocomp and its customers in the 2024 fiscal year. The company estimates that the demand in the Semiconductor segment will gradually recover starting from the first half of 2024, while at the same time unloading high inventory lev
Tryg shares are traded ex-dividend18.4.2024 08:30:00 CEST | Press release
Today, 18 April 2024, Tryg shares are traded ex-dividend of DKK 1.95. Attachment Tryg shares are traded ex_dividend
Tryg-aktier handles eksklusive udbytte18.4.2024 08:30:00 CEST | pressemeddelelse
Tryg-aktier handles i dag den 18. april 2024 eksklusive udbytte på 1,95 DKK. Vedhæftet fil Tryg-aktier handles eksklusive udbytte
JDE Peet’s signs MOUs with Honduras, Peru and Rwanda to combat coffee-related deforestation18.4.2024 08:10:00 CEST | Press release
PRESS RELEASE Amsterdam 18 April 2024 JDE Peet’s (EURONEXT: JDEP) has expanded its global effort to combat coffee-related deforestation by signing three Memoranda of Understanding (MOUs) with Peru, Honduras and Rwanda. This not only ensures continued access to the European market for smallholder farmers upon implementation of the EU Deforestation Regulation (EUDR), but crucially also fosters climate change resilience for coffee, which is imperative to ensuring that JDE Peet’s’ customers and consumers have continued access to a diversity of high-quality coffee products. JDE Peet’s has already signed MOUs to combat deforestation with Ethiopia, Papua New Guinea, Tanzania and Uganda. Honduras, Peru and Rwanda are committed to implementing JDE Peet’s’ innovative strategy to ensure all coffee is EUDR compliant, including the identification of coffee plots grown on land deforested after the 2020 cut-off date. A mutually agreed protocol will ensure that any coffee found to be in contravention
Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 202518.4.2024 08:00:00 CEST | Press release
NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR IN OR INTO AUSTRALIA, CANADA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. Pharming Group N.V. launches new convertible bond offering and simultaneously invites holders of its outstanding €125 million 3.00% convertible bonds due 2025 to offer their convertible bonds for purchase for cash Leiden, the Netherlands, 18th April, 2024: Pharming Group N.V. ("Pharming" or the "Company") (Euronext Amsterdam: PHARM) launches today the issue of approximately €100 million senior unsecured convertible bonds due 2029 (the “New Bonds”) convertible into new and/or existing ordinary shares in the capital of the Company (the “Shares”) and concurrently invites current holders of its outstanding €125 million 3.00% convertible bonds due 2025 to submit offers to sell for cash. The New Bonds are expected to be issued on 25th April 2024 (the “Issue Date”) and to carry a coupon of 4.50% per a